DNA methylation of tumor suppressor genes located on chromosome 3p in non-small cell lung cancer

Chinese Journal of Lung Cancer

Volumn 14, Issue 3, 2011, Pages 233-238

  Song, Haizhu ^a   Yi, Jun ^a   Zhang, Youwei ^a   Wang, Rui ^a   Chen, Longbang ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Biomarker; Chromosome; Lung neoplasms; Methylation

Indexed keywords

ADVANCED CANCER; ARTICLE; CANCER STAGING; CHROMOSOME 3P; CONTROLLED STUDY; DLEC1 GENE; DNA METHYLATION; DOWN REGULATION; EPIGENETICS; FHIT GENE; GENE LOCATION; HISTOPATHOLOGY; HMLH1 GENE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; PATHOGENESIS; POLYMERASE CHAIN REACTION; PROMOTER REGION; RARBETA GENE; RASSF1A GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CHROMOSOMES, HUMAN, PAIR 3; DNA METHYLATION; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; TUMOR SUPPRESSOR PROTEINS;

EID: 79953205625     PISSN: 10093419     EISSN: 19996187     Source Type: Journal    
DOI: 10.3779/j.issn.1009-3419.2011.03.09     Document Type: Article

References (16)

1. Zhang YW, Chen LB. DNA methylation and non-small cell lung cancer. Chin J Lung Cancer, 2010, 13(8): 821-826. (Chinese Source, 2010, 13(8): 821-826.)
2. Mei XY, Sun YJ, Xu MQ, et al. Research of loss of heterozygaity on chromosome 3p in non-small cell lung cancer. Chin J Lung Cancer, 2008, 11(4): 534-537. (Chinese Source, 2008, 11(4): 534-537.)
3. Zabarovsky ER, Lerman MI, Minna JD. Tumor suppressor genes on chromosome 3p involved in the pathogenesis of lung and other cancers. Oncogene, 2002, 21(45): 6915-6935.
4. Anglim PP, Alonzo TA, Laird-Offringa IA. DNA methylation-based biomarkers for early detection of non-small cell lung cancer: an update. Mol Cancer, 2008, 7: 81.
5. Daigo Y, Nishiwaki T, Kawasoe T, et al. Molecular cloning of a candidate tumor suppressor gene, DLC1, from chromosome 3p21.3. Cancer Res, 1999, 59(8): 1966-1972.
6. Qiu GH, Salto-Tellez M, Ross JA, et al. The tumor suppressor gene DLEC1 is frequently silenced by DNA methylation in hepatocellular carcinoma and induces G1 arrest in cell cycle. J Hepatol, 2008, 48(3): 433-441.
7. Wang Y, Yu Z, Wang T, et al. Identification of epigenetic aberrant promoter methylation of RASSF1A in serum DNA and its clinicopathological significance in lung cancer. Lung Cancer, 2007, 56(2): 289-294.
8. Tomizawa Y, Iijima H, Nomoto T, et al. Clinicopathological significance of aberrant methylation of RARbeta2 at 3p24, RASSF1A at 3p21.3, and FHIT at 3p14.2 in patients with non-small cell lung cancer. Lung Cancer, 2004, 46(3): 305-312.
9. Geng X, Wang F, Zhang L, et al. Loss of heterozygosity combined with promoter hypermethylation, the main mechanism of human MutL Homolog (hMLH1) gene inactivation in non-small cell lung cancer in a Chinese population. Tumori, 2009, 95(4): 488-494.
10. Yang ZH, Liu HM, He J, et al. The aberrantmethylation of fragile histidine triad (FHIT) gene and its significance of the expression of FHIT protein in lung cancer. Tumor, 2007, 27(11): 902-906. (Chinese Source, 2007, 27(11): 902-906.)
11. Verri C, Roz L, Conte D, et al. Fragile histidine triad gene inactivation in lung cancer: the European Early Lung Cancer project. Am J Respir Crit Care Med, 2009, 179(5): 396-401.
12. Kwong J, Lee JY, Wong KK, et al. Candidate tumor-suppressor gene DLEC1 is frequently downregulated by promoter hypermethylation and histone hypoacetylation in human epithelial ovarian cancer. Neoplasia, 2006, 8(4): 268-278.
13. Kwong J, Chow LS, Wong AY, et al. Epigenetic inactivation of the deleted in lung and esophageal cancer 1 gene in nasopharyngeal carcinoma. Genes Chromosomes Cancer, 2007, 46(2): 171-180.
14. Ying J, Poon FF, Yu J, et al. DLEC1 is a functional 3p22.3 tumour suppressor silenced by promoter CpG methylation in colon and gastric cancers. Br J Cancer, 2009, 100(4): 663-669.
15. Zhang Y, Miao Y, Yi J, et al. Frequent epigenetic inactivation of deleted in lung and esophageal cancer 1 gene by promoter methylation in non-smallcell lung cancer. Clin Lung Cancer, 2010, 11(4): 264-270.
16. Seng TJ, Currey N, Cooper WA, et al. DLEC1 and MLH1 promoter methylation are associated with poor prognosis in non-small cell lung carcinoma. Br J Cancer, 2008, 99(2): 375-382.